Found: 139
Select item for more details and to access through your institution.
RE: Immune Checkpoint Profiles in Luminal B Breast Cancer (Alliance).
- Published in:
- 2020
- By:
- Publication type:
- letter
A Three-Arm Randomized Phase II Study of Oral Vinorelbine Plus Capecitabine Versus Oral Vinorelbine and Capecitabine in Sequence Versus Docetaxel Plus Capecitabine in Patients with Metastatic Breast Cancer Previously Treated with Anthracyclines.
- Published in:
- Breast Journal, 2013, v. 19, n. 3, p. 240, doi. 10.1111/tbj.12098
- By:
- Publication type:
- Article
Anti-PD1 therapy induces lymphocyte-derived exosomal miRNA-4315 release inhibiting Bim-mediated apoptosis of tumor cells.
- Published in:
- Cell Death & Disease, 2020, v. 11, n. 12, p. 1, doi. 10.1038/s41419-020-03224-z
- By:
- Publication type:
- Article
Regulation of senescence escape by TSP1 and CD47 following chemotherapy treatment.
- Published in:
- Cell Death & Disease, 2019, v. 10, n. 3, p. 1, doi. 10.1038/s41419-019-1406-7
- By:
- Publication type:
- Article
Phase I study of onapristone, a type I antiprogestin, in female patients with previously treated recurrent or metastatic progesterone receptor-expressing cancers.
- Published in:
- PLoS ONE, 2018, v. 13, n. 10, p. 1, doi. 10.1371/journal.pone.0204973
- By:
- Publication type:
- Article
Gene-expression signature functional annotation of breast cancer tumours in function of age.
- Published in:
- BMC Medical Genomics, 2015, v. 8, p. 1, doi. 10.1186/s12920-015-0153-6
- By:
- Publication type:
- Article
A Phase I, Dose-Escalation Trial of Pazopanib in Combination with Cisplatin in Patients with Advanced Solid Tumors: A UNICANCER Study.
- Published in:
- Oncology & Therapy, 2016, v. 4, n. 2, p. 211, doi. 10.1007/s40487-016-0027-x
- By:
- Publication type:
- Article
An Update on the Clinical Use of CDK4/6 Inhibitors in Breast Cancer.
- Published in:
- Drugs, 2018, v. 78, n. 13, p. 1353, doi. 10.1007/s40265-018-0972-9
- By:
- Publication type:
- Article
BCL-X<sub>L</sub> directly modulates RAS signalling to favour cancer cell stemnessa.
- Published in:
- Nature Communications, 2017, v. 8, n. 1, p. 1, doi. 10.1038/s41467-017-01079-1
- By:
- Publication type:
- Article
Functional pre-therapeutic evaluation by genome editing of variants of uncertain significance of essential tumor suppressor genes.
- Published in:
- Genome Medicine, 2021, v. 13, n. 1, p. 1, doi. 10.1186/s13073-021-00976-x
- By:
- Publication type:
- Article
Forum theater staging of difficult encounters with patients to increase empathy in students: evaluation of efficacy at The University of Angers Medical School.
- Published in:
- BMC Medical Education, 2020, v. 20, n. 1, p. 1, doi. 10.1186/s12909-020-1965-4
- By:
- Publication type:
- Article
OLFM4 Expression in Ductal Carcinoma In Situ and in Invasive Breast Cancer Cohorts by a SWATH‐Based Proteomic Approach.
- Published in:
- Proteomics, 2019, v. 19, n. 21/22, p. N.PAG, doi. 10.1002/pmic.201800446
- By:
- Publication type:
- Article
iTRAQ‐Based Quantitative Proteomic Analysis Strengthens Transcriptomic Subtyping of Triple‐Negative Breast Cancer Tumors.
- Published in:
- Proteomics, 2019, v. 19, n. 21/22, p. N.PAG, doi. 10.1002/pmic.201800484
- By:
- Publication type:
- Article
Effect of Everolimus on Bone Marker Levels and Progressive Disease in Bone in BOLERO-2.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2013, v. 105, n. 9, p. 654, doi. 10.1093/jnci/djt026
- By:
- Publication type:
- Article
bc-GenExMiner 4.5: new mining module computes breast cancer differential gene expression analyses.
- Published in:
- Database: The Journal of Biological Databases & Curation, 2021, v. 2021, p. 1, doi. 10.1093/database/baab007
- By:
- Publication type:
- Article
bc-GenExMiner 3.0: new mining module computes breast cancer gene expression correlation analyses.
- Published in:
- Database: The Journal of Biological Databases & Curation, 2013, v. 2013, p. 1, doi. 10.1093/database/bas060
- By:
- Publication type:
- Article
Survival Impact of Locoregional Treatment of the Primary Tumor in De Novo Metastatic Breast Cancers in a Large Multicentric Cohort Study: A Propensity Score-Matched Analysis.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2019, v. 26, n. 2, p. 356, doi. 10.1245/s10434-018-6831-9
- By:
- Publication type:
- Article
Did the COVID-19 pandemic delay treatment for localized breast cancer patients? A multicenter study.
- Published in:
- PLoS ONE, 2024, v. 19, n. 5, p. 1, doi. 10.1371/journal.pone.0304556
- By:
- Publication type:
- Article
Bcl-2 expression and prognostic significance in feline invasive mammary carcinomas: a retrospective observational study.
- Published in:
- BMC Veterinary Research, 2019, v. 15, n. 1, p. N.PAG, doi. 10.1186/s12917-018-1772-x
- By:
- Publication type:
- Article
p4EBP1 staining predicts outcome in ER-positive endocrine-resistant metastatic breast cancer patients treated with everolimus and exemestane.
- Published in:
- British Journal of Cancer, 2024, v. 130, n. 4, p. 613, doi. 10.1038/s41416-023-02549-8
- By:
- Publication type:
- Article
Patterns of genomic change in residual disease after neoadjuvant chemotherapy for estrogen receptor-positive and HER2-negative breast cancer.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Clinical utility of circulating tumour cell-based monitoring of late-line chemotherapy for metastatic breast cancer: the randomised CirCe01 trial.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Erratum to: Everolimus Plus Exemestane in Postmenopausal Patients with HR Breast Cancer: BOLERO-2 Final Progression-Free Survival Analysis.
- Published in:
- 2014
- By:
- Publication type:
- Erratum
Everolimus plus exemestane in postmenopausal patients with HR(+) breast cancer: BOLERO-2 final progression-free survival analysis.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Everolimus Plus Exemestane in Postmenopausal Patients with HR<sup>+</sup> Breast Cancer: BOLERO-2 Final Progression-Free Survival Analysis.
- Published in:
- Advances in Therapy, 2013, v. 30, n. 10, p. 870, doi. 10.1007/s12325-013-0060-1
- By:
- Publication type:
- Article
Mutational Profile of Metastatic Breast Cancers: A Retrospective Analysis.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Neoadjuvant anthracycline-based (5-FEC) or anthracycline-free (docetaxel/carboplatin) chemotherapy plus trastuzumab and pertuzmab in HER2 + BC patients according to their TOP2A: a multicentre, open-label, non-randomized phase II trial.
- Published in:
- Breast Cancer Research & Treatment, 2024, v. 205, n. 2, p. 267, doi. 10.1007/s10549-024-07285-y
- By:
- Publication type:
- Article
Radium-223 in women with hormone receptor-positive bone-metastatic breast cancer receiving endocrine therapy: pooled analysis of two international, phase 2, randomized, double-blind, placebo-controlled trials.
- Published in:
- Breast Cancer Research & Treatment, 2024, v. 204, n. 2, p. 249, doi. 10.1007/s10549-023-07147-z
- By:
- Publication type:
- Article
Pattern and risk factors of isolated local relapse among women with hormone receptor-positive and HER2-negative breast cancer and lymph node involvement: 10-year follow-up analysis of the PACS 01 and PACS 04 trials.
- Published in:
- Breast Cancer Research & Treatment, 2023, v. 199, n. 2, p. 371, doi. 10.1007/s10549-023-06912-4
- By:
- Publication type:
- Article
Ribociclib plus letrozole in male patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer: subgroup analysis of the phase IIIb CompLEEment-1 trial.
- Published in:
- Breast Cancer Research & Treatment, 2022, v. 193, n. 1, p. 95, doi. 10.1007/s10549-022-06543-1
- By:
- Publication type:
- Article
Correction to: Full population results from the core phase of CompLEEment-1, a phase 3b study of ribociclib plus letrozole as first-line therapy for advanced breast cancer in an expanded population.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Full population results from the core phase of CompLEEment-1, a phase 3b study of ribociclib plus letrozole as first-line therapy for advanced breast cancer in an expanded population.
- Published in:
- Breast Cancer Research & Treatment, 2021, v. 189, n. 3, p. 689, doi. 10.1007/s10549-021-06334-0
- By:
- Publication type:
- Article
Safety and efficacy of abemaciclib plus endocrine therapy in older patients with hormone receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer: an age-specific subgroup analysis of MONARCH 2 and 3 trials.
- Published in:
- Breast Cancer Research & Treatment, 2021, v. 186, n. 2, p. 417, doi. 10.1007/s10549-020-06029-y
- By:
- Publication type:
- Article
Health-related quality of life of postmenopausal women with hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer treated with ribociclib + letrozole: results from MONALEESA-2.
- Published in:
- Breast Cancer Research & Treatment, 2018, v. 170, n. 3, p. 535, doi. 10.1007/s10549-018-4769-z
- By:
- Publication type:
- Article
First-line ribociclib plus letrozole in postmenopausal women with HR+ , HER2− advanced breast cancer: Tumor response and pain reduction in the phase 3 MONALEESA-2 trial.
- Published in:
- Breast Cancer Research & Treatment, 2018, v. 169, n. 3, p. 469, doi. 10.1007/s10549-017-4658-x
- By:
- Publication type:
- Article
Efficacy of palbociclib plus fulvestrant after everolimus in hormone receptor-positive metastatic breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2018, v. 168, n. 2, p. 559, doi. 10.1007/s10549-017-4623-8
- By:
- Publication type:
- Article
Canine invasive mammary carcinomas as models of human breast cancer. Part 1: natural history and prognostic factors.
- Published in:
- Breast Cancer Research & Treatment, 2018, v. 167, n. 3, p. 635, doi. 10.1007/s10549-017-4548-2
- By:
- Publication type:
- Article
Ribociclib with letrozole vs letrozole alone in elderly patients with hormone receptor-positive, HER2-negative breast cancer in the randomized MONALEESA-2 trial.
- Published in:
- Breast Cancer Research & Treatment, 2018, v. 167, n. 3, p. 659, doi. 10.1007/s10549-017-4523-y
- By:
- Publication type:
- Article
Canine invasive mammary carcinomas as models of human breast cancer. Part 2: immunophenotypes and prognostic significance.
- Published in:
- Breast Cancer Research & Treatment, 2018, v. 167, n. 2, p. 459, doi. 10.1007/s10549-017-4542-8
- By:
- Publication type:
- Article
A randomized phase II trial of ridaforolimus, dalotuzumab, and exemestane compared with ridaforolimus and exemestane in patients with advanced breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2017, v. 165, n. 3, p. 601, doi. 10.1007/s10549-017-4375-5
- By:
- Publication type:
- Article
A non-randomized dose-escalation Phase I trial of a protein-based immunotherapeutic for the treatment of breast cancer patients with HER2-overexpressing tumors.
- Published in:
- Breast Cancer Research & Treatment, 2016, v. 156, n. 2, p. 319, doi. 10.1007/s10549-016-3751-x
- By:
- Publication type:
- Article
A phase I/II trial of the safety and clinical activity of a HER2-protein based immunotherapeutic for treating women with HER2-positive metastatic breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2016, v. 156, n. 2, p. 301, doi. 10.1007/s10549-016-3750-y
- By:
- Publication type:
- Article
Bone mineral density and circulating biomarkers in the BIG 1-98 trial comparing adjuvant letrozole, tamoxifen and their sequences.
- Published in:
- Breast Cancer Research & Treatment, 2014, v. 144, n. 2, p. 321, doi. 10.1007/s10549-014-2849-2
- By:
- Publication type:
- Article
Everolimus plus exemestane as first-line therapy in HR, HER2 advanced breast cancer in BOLERO-2.
- Published in:
- Breast Cancer Research & Treatment, 2014, v. 143, n. 3, p. 459, doi. 10.1007/s10549-013-2814-5
- By:
- Publication type:
- Article
Cancer du sein métastatique.
- Published in:
- Oncologie (Tech Science Press), 2008, v. 10, n. 2, p. 136, doi. 10.1007/s10269-008-0838-y
- By:
- Publication type:
- Article
Adjuvant endocrine therapy uptake, toxicity, quality of life, and prediction of early discontinuation.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2023, v. 115, n. 9, p. 1099, doi. 10.1093/jnci/djad109
- By:
- Publication type:
- Article
Onapristone Extended Release: Safety Evaluation from Phase I–II Studies with an Emphasis on Hepatotoxicity.
- Published in:
- Drug Safety, 2020, v. 43, n. 10, p. 1045, doi. 10.1007/s40264-020-00964-x
- By:
- Publication type:
- Article
Clinical utility of pembrolizumab in the management of advanced solid tumors: an evidence-based review on the emerging new data.
- Published in:
- Cancer Management & Research, 2019, v. 11, p. 4297, doi. 10.2147/CMAR.S151023
- By:
- Publication type:
- Article
A phase I/II study of epertinib plus trastuzumab with or without chemotherapy in patients with HER2-positive metastatic breast cancer.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Identification of three subtypes of triple-negative breast cancer with potential therapeutic implications.
- Published in:
- 2019
- By:
- Publication type:
- journal article